Research has found that pre-S2 mutants initiate the glycolytic via activate mTOR signal pathway and activate SLC2A1 in YY1-dependent transcription, contributing to increased aerobic glycolysis, glucose uptake, lactic acid production and release in advanced tumorigenesis of HCC (106). This evidence concerns the gene YY1 and hepatocellular carcinoma.